These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27222379)

  • 1. Effects of WR1065 on 6-hydroxydopamine-induced motor imbalance: Possible involvement of oxidative stress and inflammatory cytokines.
    Kheradmand A; Nayebi AM; Jorjani M; Khalifeh S; Haddadi R
    Neurosci Lett; 2016 Aug; 627():7-12. PubMed ID: 27222379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrodin microinjection suppresses 6-OHDA-induced motor impairments in parkinsonian rats: insights into oxidative balance and microglial activation in SNc.
    Haddadi R; Poursina M; Zeraati F; Nadi F
    Inflammopharmacology; 2018 Oct; 26(5):1305-1316. PubMed ID: 29616453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats.
    Haddadi R; Mohajjel Nayebi A; Brooshghalan SE
    Neurosci Lett; 2013 Oct; 555():106-11. PubMed ID: 24045063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal degeneration and oxidative stress in the SNc of 6-OHDA intoxicated rats; improving role of silymarin long-term treatment.
    Haddadi R; Eyvari-Brooshghalan S; Nayebi AM; Sabahi M; Ahmadi SA
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2427-2437. PubMed ID: 32715318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silymarin improved 6-OHDA-induced motor impairment in hemi-parkisonian rats: behavioral and molecular study.
    Haddadi R; Nayebi AM; Farajniya S; Brooshghalan SE; Sharifi H
    Daru; 2014 Apr; 22(1):38. PubMed ID: 24726284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMER28 Attenuates Dopaminergic Toxicity Mediated by 6-Hydroxydopamine in the Rats via Modulating Oxidative Burdens and Autophagy-Related Parameters.
    Darabi S; Noori-Zadeh A; Rajaei F; Abbaszadeh HA; Bakhtiyari S; Roozbahany NA
    Neurochem Res; 2018 Dec; 43(12):2313-2323. PubMed ID: 30288644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.
    Roghani M; Niknam A; Jalali-Nadoushan MR; Kiasalari Z; Khalili M; Baluchnejadmojarad T
    Brain Res Bull; 2010 Jul; 82(5-6):279-83. PubMed ID: 20558255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of Althaea officinalis L. extract in 6-hydroxydopamine-induced hemi-Parkinsonism model: behavioral, biochemical and histochemical evidence.
    Rezaei M; Alirezaei M
    J Physiol Sci; 2014 May; 64(3):171-6. PubMed ID: 24464760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
    Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
    Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat.
    Zare K; Eidi A; Roghani M; Rohani AH
    Metab Brain Dis; 2015 Feb; 30(1):205-13. PubMed ID: 25123753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Chronic Administration of Buspirone and Fluoxetine on Inflammatory Cytokines in 6-Hydroxydopamine-lesioned Rats.
    Sharifi H; Nayebi AM; Farajnia S; Haddadi R
    Drug Res (Stuttg); 2015 Aug; 65(8):393-7. PubMed ID: 24782287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
    Kumar A; Sharma N; Gupta A; Kalonia H; Mishra J
    Brain Res; 2012 Aug; 1471():13-22. PubMed ID: 22789904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
    Singh S; Mishra A; Shukla S
    Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism.
    Jalali-Nadoushan M; Roghani M
    Brain Res; 2013 Apr; 1505():68-74. PubMed ID: 23415934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
    Kopalli SR; Noh SJ; Koppula S; Suh YH
    Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences.
    Zafar KS; Siddiqui A; Sayeed I; Ahmad M; Salim S; Islam F
    J Neurochem; 2003 Feb; 84(3):438-46. PubMed ID: 12558963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat.
    Afshin-Majd S; Khalili M; Roghani M; Mehranmehr N; Baluchnejadmojarad T
    Mol Neurobiol; 2015; 51(3):1064-70. PubMed ID: 24939694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson's disease.
    Kumari N; Agrawal S; Kumari R; Sharma D; Luthra PM
    Neurosci Lett; 2018 May; 675():74-82. PubMed ID: 29567422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
    Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
    Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.